FDA Adverse Event Injury Summary report: N

INGEVITY MRI

MDR report key: 17904575 · Received October 10, 2023

Report

Report Number
2124215-2023-55902
Event Type
Injury
Date Received
October 10, 2023
Date of Event
September 27, 2023
Report Date
December 19, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NVN
UDI-DI
00802526523427
PMA / PMN Number
P150012/S000
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDED CODE FOR UN-RETRIEVED DEVICE FRAGMENTS UPON REVIEW BY OUR MEDICAL TEAM.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM HAD A STORED SIGNAL ARTIFACT MONITOR (SAM) EPISODE. TECHNICAL SERVICES (TS) EXAMINED DEVICE EPISODE DATA AND FOUND THAT THERE WAS OVERSENSING OF RESPIRATORY RATE TREND (RRT) NOISE WITH INHIBITION OF PACING FOR ONE BEAT ON THE RIGHT ATRIAL (RA) LEAD CHANNEL. THE PACING IMPEDANCE VALUES FOR THE RA LEAD WERE GREATER THAN 3000 OHMS, WHICH WAS OUT OF RANGE. THE PATIENT WAS TESTED IN CLINIC, INCLUDING ISOMETRICS AND MANIPULATIONS, AND IT WAS FOUND THAT THE SENSING ON THE RA LEAD WAS LOW AND INTERMITTENT WITH NO CAPTURE AT MAXIMUM OUTPUT. IT WAS NOTED THAT THE PLAN IS TO EXTRACT THE RA LEAD AT A LATER DATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. CURRENTLY, THIS ICD SYSTEM REMAINS IN SERVICE. ACCORDING TO ADDITIONAL INFORMATION, THIS LEAD WAS EXPLANTED DUE TO A FRACTURE AND SUBSEQUENTLY REPLACED WITH A NEW RA LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. AS OF TODAY, THIS PRODUCT HAS NOT BEEN RECEIVED BY BOSTON SCIENTIFIC FOR FURTHER INVESTIGATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM HAD A STORED SIGNAL ARTIFACT MONITOR (SAM) EPISODE. TECHNICAL SERVICES (TS) EXAMINED DEVICE EPISODE DATA AND FOUND THAT THERE WAS OVERSENSING OF RESPIRATORY RATE TREND (RRT) NOISE WITH INHIBITION OF PACING FOR ONE BEAT ON THE RIGHT ATRIAL (RA) LEAD CHANNEL. THE PACING IMPEDANCE VALUES FOR THE RA LEAD WERE GREATER THAN 3000 OHMS, WHICH WAS OUT OF RANGE. THE PATIENT WAS TESTED IN CLINIC, INCLUDING ISOMETRICS AND MANIPULATIONS, AND IT WAS FOUND THAT THE SENSING ON THE RA LEAD WAS LOW AND INTERMITTENT WITH NO CAPTURE AT MAXIMUM OUTPUT. IT WAS NOTED THAT THE PLAN IS TO EXTRACT THE RA LEAD AT A LATER DATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. CURRENTLY, THIS ICD SYSTEM REMAINS IN SERVICE. ACCORDING TO ADDITIONAL INFORMATION, THIS LEAD WAS EXPLANTED AND REPLACED WITH A NEW RA LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. AS OF TODAY, THIS PRODUCT HAS NOT BEEN RECEIVED BY BOSTON SCIENTIFIC FOR FURTHER INVESTIGATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM HAD A STORED SIGNAL ARTIFACT MONITOR (SAM) EPISODE. TECHNICAL SERVICES (TS) EXAMINED DEVICE EPISODE DATA AND FOUND THAT THERE WAS OVERSENSING OF RESPIRATORY RATE TREND (RRT) NOISE WITH INHIBITION OF PACING FOR ONE BEAT ON THE RIGHT ATRIAL (RA) LEAD CHANNEL. THE PACING IMPEDANCE VALUES FOR THE RA LEAD WERE GREATER THAN 3000 OHMS, WHICH WAS OUT OF RANGE. THE PATIENT WAS TESTED IN CLINIC, INCLUDING ISOMETRICS AND MANIPULATIONS, AND IT WAS FOUND THAT THE SENSING ON THE RA LEAD WAS LOW AND INTERMITTENT WITH NO CAPTURE AT MAXIMUM OUTPUT. IT WAS NOTED THAT THE PLAN IS TO EXTRACT THE RA LEAD AT A LATER DATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. CURRENTLY, THIS ICD SYSTEM REMAINS IN SERVICE. ACCORDING TO ADDITIONAL INFORMATION, THIS LEAD WAS EXPLANTED DUE TO A FRACTURE AND SUBSEQUENTLY REPLACED WITH A NEW RA LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. AS OF TODAY, THIS PRODUCT HAS NOT BEEN RECEIVED BY BOSTON SCIENTIFIC FOR FURTHER INVESTIGATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM HAD A STORED SIGNAL ARTIFACT MONITOR (SAM) EPISODE. TECHNICAL SERVICES (TS) EXAMINED DEVICE EPISODE DATA AND FOUND THAT THERE WAS OVERSENSING OF RESPIRATORY RATE TREND (RRT) NOISE WITH INHIBITION OF PACING FOR ONE BEAT ON THE RIGHT ATRIAL (RA) LEAD CHANNEL. THE PACING IMPEDANCE VALUES FOR THE RA LEAD WERE GREATER THAN 3000 OHMS, WHICH WAS OUT OF RANGE. THE PATIENT WAS TESTED IN CLINIC, INCLUDING ISOMETRICS AND MANIPULATIONS, AND IT WAS FOUND THAT THE SENSING ON THE RA LEAD WAS LOW AND INTERMITTENT WITH NO CAPTURE AT MAXIMUM OUTPUT. IT WAS NOTED THAT THE PLAN IS TO EXTRACT THE RA LEAD AT A LATER DATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. CURRENTLY, THIS ICD SYSTEM REMAINS IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
335733 INGEVITY MRI IMPLANTABLE LEAD NVN BOSTON SCIENTIFIC CORPORATION 7740 704506 00802526523427

Patients

Seq Age Sex Outcome Treatment
1 17 YR Male Hospitalization| R